Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma

Table 5 Multivariable analysis of the total CD34⁺ cell yield in 39 patients with high-risk non-Hodgkin’s lymphoma

Parameter	Total CD34⁺ cell yield (×10⁶ cells/kg body weight)
Parameter	B	95% CI	P value
Percentage of CD34⁺ cells in peripheral blood on the first day of apheresis	1.886	1.104 to 2.669	<0.001
Previous chemotherapy cycles	−0.07	−1.386 to 1.245	0.914
Duration of rhG-CSF support	−0.829	−1.685 to 0.028	0.058
Time from mobilization to apheresis	−0.736	−1.544 to 0.073	0.073
Age	−3.718	−6.521 to −0.914	0.011

ISSN: 2523-3548